In the largest settlement of its kind, Teva Pharmaceuticals agreed to pay $425 million to resolve allegations the company and a related business paid kickbacks to charitable foundations in order ...

Teva “spread information contradicted by health authorities’ findings, seeking to sow doubt on the safety, efficacy and therapeutic equivalence of the rival product,” the EU Commission said.

BOSTON, Oct 10 (Reuters) - Teva Pharmaceutical Industries Ltd (TEVA.TA), opens new tab has agreed to pay $450 million to resolve allegations it used charities that help cover Medicare patients ...

Teva Pharmaceuticals TEVA-0.81%decrease; red down pointing triangle will pay $450 million to resolve allegations that the generic drug manufacturer submitted false claims and violated a federal ...

Oct. 10 (UPI) --Teva Pharmaceuticals, the largest generic drug manufacturer in the United States, has agreed to pay $450 million to resolve two claims that allege the company violated the Anti ...

Teva CMO Eric Hughes, M.D., Ph.D. (Teva) Teva’s mid- and late-stage pipeline largely hinges on four drugs, each of which falls into one of the company’s historic specialties in neuroscience ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

TVB-009P, Teva’s proposed biosimilar to Prolia, is the first of Teva’s internally developed biosimilars to be submitted to the U.S. FDA. The submissions are supported by a comprehensive ...

Teva Pharmaceuticals Industries Ltd (NYSE:TEVA) has agreed to a $450 million settlement with the U.S. government to resolve allegations that they violated the Anti-Kickback Statute (AKS) and the ...

BRUSSELS (AP) — The European Commission said Thursday it has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly seeking to protect the patent for its ...

21, 2024, in Beverly Hills, Mich. BRUSSELS – The European Commission said Thursday it has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly seeking ...